UPDATE: Needham & Company Downgrades Teladoc (TDOC) to Hold

Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'

JPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.

The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More

Teladoc Crashes on Very Light Guidance, Prompts Two Downgrades

Shares of Teladoc (NYSE: TDOC) are down as much as 23% in premarket trading Thursday after the companys guidance for Q3 adjusted EBITDA fell short of analyst estimates.

The company reported a Q2 loss per share of $19.22, compared to a loss per share of 86c in the year-ago period and the expected loss per share of 59c. Revenue stood at $592.4 million in the quarter, up 18% YoY, and above the consensus estimates of $587 million.

For the third... More

UPDATE: Goldman Sachs Downgrades Teladoc (TDOC) to Neutral

(Updated - July 28, 2022 7:02 AM EDT)

Goldman Sachs analyst Cindy Motz downgraded Teladoc (NYSE: TDOC) from Buy to Neutral with a price target of $36.00 (from $55.00).

The analyst comments "We downgrade our rating to Neutral from Buy and lower our 12-month price target to $36 from $55. While TDOC posted solid results that were ahead of expectations for 2Q22, their guidance for the 3Q22 in terms of adjusted EBITDA was considerably below... More

Teladoc (TDOC) PT Lowered to $53 at RBC Capital

RBC Capital analyst Sean Dodge lowered the price target on Teladoc (NYSE: TDOC) to $53.00 (from $65.00) while maintaining a Outperform rating.... More

Teladoc (TDOC) PT Lowered to $40 at Piper Sandler

Piper Sandler analyst Jessica Tassan lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $42.00) while maintaining a Overweight rating.... More

Teladoc (TDOC) PT Lowered to $28 at Evercore ISI

Evercore ISI analyst Elizabeth Anderson lowered the price target on Teladoc (NYSE: TDOC) to $28.00 (from $32.00) while maintaining a In Line rating.... More

Teladoc (TDOC) PT Lowered to $30 at Stifel

Stifel analyst David Grossman lowered the price target on Teladoc (NYSE: TDOC) to $30.00 (from $36.00) while maintaining a Hold rating.... More

After-Hours Movers: Facebook, Qualcomm Fall Following Weak Outlooks

After-Hours Stock Movers:

Community Health Systems (NYSE: CYH) 48% LOWER; reported Q2 EPS of ($2.52), $2.59 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $2.93 billion versus the consensus estimate of $3.14 billion.

JAKKS Pacific (NASDAQ: JAKK) 31% HIGHER; reported Q2 EPS of $2.10, $2.53 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $220.4 million versus the consensus estimate of $122.07 million.

Teladoc (NYSE: TDOC)... More

Teladoc (TDOC) Plummet 20% on Q2 EPS Miss and Worse Than Expected Outlook

Teladoc (NYSE: TDOC) shares plunged more than 20% after-hours following the companys reported Q2 results, with EPS of ($19.22) coming in significantly lower than the consensus estimate of ($0.64). Revenue increased 18% year-over-year to $592.4 million, compared to the consensus estimate of $587.71 million.

Access fees revenue came in at... More

Teladoc (TDOC) Misses Q2 EPS

Teladoc (NYSE: TDOC) reported Q2 EPS of ($19.22), which may not compare to the analyst estimate of ($0.64). Revenue for the quarter came in at $592.4 million versus the consensus estimate of $587.71 million.

GUIDANCE:

Teladoc sees Q3 2022 EPS of ($0.85)-($0.60), versus the consensus... More

Teladoc (TDOC) call put ratio 1 call to 1.4 puts into quarter results and outlook

Teladoc (NYSE: TDOC) 30-day option implied is at 108; compared to its 52-week range of 37 to 108 into the release of quarter results today after the bell.